Showing 1751-1760 of 7447 results for "".
Skin Cancer 2024: Trends, Updates, and What’s Next
https://practicaldermatology.com/columns/skin-cancer-updates/skin-cancer-2024-trends-updates-and-whats-next/24214/Corey Hartman, MD, FAAD, talks about trends and issues to watch in 2024 in the subspecialty of skin cancer.Finding Influencers to Promote Your Dermatology Practice
https://practicaldermatology.com/topics/practice-management/finding-influencers-to-promote-your-dermatology-practice/23757/Influencer marketing is not simply a form of paid advertisement; it is based on a mutually beneficial partnership.OTC Skincare Today
https://practicaldermatology.com/issues/supplements/otc-skincare-today/23247/Can dermatologists afford to ignore patients’ growing use of OTC products?Credit Card on File: Benefit or Liability?
https://practicaldermatology.com/topics/practice-management/credit-card-on-file-benefit-or-liability/20422/Think twice before asking patients for a credit card number to keep on file.Mind the Gap (Year): Being Mindful of Dedicating a Year to Research During Medical School
https://practicaldermatology.com/topics/practice-management/mind-the-gap-year-being-mindful-of-dedicating-a-year-to-research-during-medical-school/23783/A research year can have benefits, but it may not give residency applicants the edge they expect.Telephone Mystery Shopping and Converting New Patients
https://practicaldermatology.com/issues/april-2025/telephone-mystery-shopping-and-converting-new-patients/35621/Even with today’s market focused on online digital marketing, a practice’s biggest revenue source opportunity still seems to be the phones. The first interaction most new patients have with a practice is on the phone, which used to be about 99% of the time; now, we believe it is about 80%.Emrosi Launched in the US for Rosacea
https://practicaldermatology.com/series/dermwire-tv/emrosi-launched-in-the-us-for-rosacea/33943/In this week's DermwireTV, a new treatment for rosacea is launched in the US; long-term data is presented for tapinarof 1% cream for atopic dermatitis; and in our C-Suite Chats segment, we speak with the CEO and Co-Founder of Mama Sol.I Came In Like a Wrecking Ball
https://practicaldermatology.com/issues/practicaldermatology-com-march-2025/i-came-in-like-a-wrecking-ball/33162/I have to start by warning you, dear reader, that I am writing my first editorial for Practical Dermatology immediately after typing up four appeal letters to insurance companies.Updates in Vulvar Dermatology
https://practicaldermatology.com/conferences/masterclasses-in-dermatology-2025/updates-in-vulvar-dermatology/33012/Melissa Mauskar, MD, an associate professor and director of the vulvar heatlh program at UT Southwestern Medical Center, talks about the importance of having dermatologists promote vulvar health and regular examination, while also working to reduce patient anxiety.Clinical Development of Emrosi for Rosacea
https://practicaldermatology.com/series/c-suite-chats/clinical-development-emrosi-rosacea/32379/Claude Maraoui, President and CEO of Journey Medical, discusses the clinical development program for Emrosi, which was recently approved by the FDA for inflammatory lesions of rosacea in adults.